BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19324254)

  • 21. Comparison of coronary plaque composition among patients with acute coronary syndrome and stable coronary artery disease.
    Li XM; Huang CX; Wang TS; Zhuang SW; Zhou H; Tian B
    Chin Med J (Engl); 2008 Mar; 121(6):534-9. PubMed ID: 18364141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipid modification on progression of coronary calcification.
    McCullough PA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S115-9. PubMed ID: 16251246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Terashima M; Michishita I;
    Coron Artery Dis; 2012 Jun; 23(4):239-44. PubMed ID: 22441135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diurnal heart rate reactivity: a predictor of severity of experimental coronary and carotid atherosclerosis.
    Bassiouny HS; Zarins CK; Lee DC; Skelly CL; Fortunato JE; Glagov S
    J Cardiovasc Risk; 2002 Dec; 9(6):331-8. PubMed ID: 12478202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synergistic relationship of elevated low-density lipoprotein cholesterol levels and systolic blood pressure with coronary artery calcification.
    Musunuru K; Nasir K; Pandey S; Campbell CC; Carvalho JA; Meneghello R; Budoff MJ; Blumenthal RS; Santos RD
    Atherosclerosis; 2008 Oct; 200(2):368-73. PubMed ID: 18243213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl.
    Kini AS; Muntner P; Moreno PR; Mann D; Krishnan P; Kim MC; Rafael OC; Farkouh ME; Sharma SK
    Am J Cardiol; 2009 Feb; 103(3):350-4. PubMed ID: 19166688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.
    Nicholls SJ; Tuzcu EM; Kalidindi S; Wolski K; Moon KW; Sipahi I; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2008 Jul; 52(4):255-62. PubMed ID: 18634979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
    Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
    Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
    Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
    Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
    Nicholls SJ; Bakris GL; Kastelein JJ; Menon V; Williams B; Armbrecht J; Brunel P; Nicolaides M; Hsu A; Hu B; Fang H; Puri R; Uno K; Kataoka Y; Bash D; Nissen SE
    JAMA; 2013 Sep; 310(11):1135-44. PubMed ID: 23999933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
    Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
    Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
    Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
    J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral arterial disease and progression of coronary atherosclerosis.
    Hussein AA; Uno K; Wolski K; Kapadia S; Schoenhagen P; Tuzcu EM; Nissen SE; Nicholls SJ
    J Am Coll Cardiol; 2011 Mar; 57(10):1220-5. PubMed ID: 21371639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.